# Selection Pressure and Evolution Induced by Immune Checkpoint Inhibitors and Other Immunologic Therapies

> **NCT02724488** · — · ACTIVE_NOT_RECRUITING · sponsor: **University Health Network, Toronto** · enrollment: 14 (actual)

## Conditions studied

- Head and Neck Cancer
- Melanoma

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT02724488
- **Lead sponsor:** University Health Network, Toronto
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2015-04
- **Primary completion:** 2027-01
- **Final completion:** 2027-01
- **Target enrollment:** 14 (ACTUAL)
- **Last updated:** 2026-01-08

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02724488

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02724488, "Selection Pressure and Evolution Induced by Immune Checkpoint Inhibitors and Other Immunologic Therapies". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT02724488. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*